SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 31.91+1.9%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas who wrote (211)7/25/1997 8:53:00 AM
From: Douglas   of 455
 
Jesselson, Michael G. of New York, NY Files SEC FORM 13D

WASHINGTON, DC, Jul. 24, 1997 (States) -- Item 5. Interest in
Securities of the Issuer: Reports that on 07-02-97, the
Reporting Person, Michael G. Jesselson, acquired 800,000 common shares
of the Issuer, Procept, Inc., for $0.375 to $0.4375 per share.

ISSUER: Procept Inc. of Cambridge, MA SHARES OWNED: 1144604
PERCENTAGE OWNED: 8.34 SEC DATE: 07/24/97 FILING DATE: 07/10/97 EVENT
DATE: 07/02/97

-0-

Copyright States News Service, all rights reserved
* * * * * * * * * *
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News